Abstract
Although the proximal cytoplasmic signaling events that control the activation of the NF-κB transcription factor are understood in considerable detail, the subsequent intranuclear events that regulate the strength and duration of the NF-κB-mediated transcriptional response remain poorly defined. Recent studies have revealed that NF-κB is subject to reversible acetylation and that this posttranslational modification functions as an intranuclear molecular switch to control NF-κB action. In this review, we summarize this new and fascinating mechanism through which the pleiotropic effects of NF-κB are regulated within the cells. NF-κB is a heterodimer composed of p50 and RelA subunits. Both subunits are acetylated at multiple lysine residues with the p300/CBP acetyltransferases playing a major role in this process in vivo. Further, the acetylation of different lysines regulates different functions of NF-κB, including transcriptional activation, DNA binding affinity, IκBα assembly, and subcellular localization. Acetylated forms RelA are subject to deacetylation by histone deacetylase 3 (HDAC3). This selective action of HDAC3 promotes IκBα binding and rapid CRM1-dependent nuclear export of the deacetylated NF-κB complex, which terminates the NF-κB response and replenishes the cytoplasmic pool of latent NF-κB/IκBα complexes. This readies the cell for the next NF-κB-inducing stimulus. Thus, reversible acetylation of RelA serves as an important intranuclear regulatory mechanism that further provides for dynamic control of NF-κB action.
Original language | English (US) |
---|---|
Pages (from-to) | 549-557 |
Number of pages | 9 |
Journal | Journal of Molecular Medicine |
Volume | 81 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1 2003 |
Externally published | Yes |
Keywords
- Acetylation
- Deacetylation
- HDAC3
- NF-κB
- RelA
- p300
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery
- Genetics(clinical)